BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
Change in Working Capital
BRAIN Biotech AG
Change in Working Capital Peer Comparison
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BRAIN Biotech AG
XETRA:BNN
|
Change in Working Capital
-€464k
|
CAGR 3-Years
61%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Wacker Chemie AG
XETRA:WCH
|
Change in Working Capital
€58.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Evonik Industries AG
XETRA:EVK
|
Change in Working Capital
€7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Covestro AG
XETRA:1COV
|
Change in Working Capital
-€4m
|
CAGR 3-Years
74%
|
CAGR 5-Years
62%
|
CAGR 10-Years
N/A
|
|
AlzChem Group AG
XETRA:ACT
|
Change in Working Capital
-€20.5m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Symrise AG
XETRA:SY1
|
Change in Working Capital
-€148.8m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-2%
|
See Also
What is BRAIN Biotech AG's Change in Working Capital?
Change in Working Capital
-464k
EUR
Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Change in Working Capital amounts to -464k EUR.
What is BRAIN Biotech AG's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
13%
The average annual Change in Working Capital growth rates for BRAIN Biotech AG have been 61% over the past three years , 13% over the past five years .